The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats

Numerous animal models have demonstrated that caloric restriction (CR) is an excellent tool to delay aging and increase the quality of life, likely because it counteracts age-induced oxidative stress and inflammation. The aging process can affect the prostate in three ways: the onset of benign prostatic hyperplasia, prostatitis, and prostate cancer. In this study, we used 14 aged male Sprague Dawley rats, which were allocated into two groups, at the age of 18 months old. One group was fed ad libitum (a normal diet (ND)), and the other group followed a caloric restriction diet with a 60% decrease in intake. The rats were sacrificed at the age of 24 months. By immunohistochemical (IHC) and Western blot (WB) analyses, we studied the variations between the two groups in immune inflammation and fibrosis-related markers in aged prostate tissues. Morphological examinations showed lower levels of prostatic hyperplasia and fibrosis in the CR rats vs. the ND rats. The IHC results revealed that the prostates of the CR rats exhibited a lower immune proinflammatory infiltrate level and a reduced expression of the NLRP3 inflammasome pathway, together with significantly reduced expressions of mesenchymal markers and the profibrotic factor TGFβ1. Finally, by WB analysis, we observed a reduced expression of ERα, which is notoriously implicated in prostate stromal proliferation, and increased expressions of SOD1 and Hsp70, both exerting protective effects against oxidative stress. Overall, these data suggest that CR brings potential benefits to prostatic tissues as it reduces the physiological immune–inflammatory processes and the tissue remodeling caused by aging.

[1]  Ousheng Liu,et al.  The role of epithelial cells in fibrosis: mechanisms and treatment. , 2024, Pharmacological research.

[2]  Qi Cai,et al.  The role of NLRP3 inflammasome in aging and age-related diseases , 2024, Immunity & ageing : I & A.

[3]  S. Taboga,et al.  Prostatic morphological changes throughout life: Cytochemistry as a tool to reveal tissue aging markers , 2024, Microscopy research and technique.

[4]  A. Chorzalska,et al.  NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype , 2023, Cell Communication and Signaling.

[5]  Isak W. Tengesdal,et al.  NLRP3 and cancer: Pathogenesis and therapeutic opportunities. , 2023, Pharmacology & therapeutics.

[6]  D. Holmannova,et al.  Non-Genomic Hallmarks of Aging—The Review , 2023, International journal of molecular sciences.

[7]  L. Barberio,et al.  Caloric Restriction Mitigates Kidney Fibrosis in an Aged and Obese Rat Model , 2023, Antioxidants.

[8]  Minfeng Chen,et al.  MIR663AHG as a competitive endogenous RNA regulating TGF‐β‐induced epithelial proliferation and epithelial–mesenchymal transition in benign prostate hyperplasia , 2023, Journal of biochemical and molecular toxicology.

[9]  Xiujuan Shi,et al.  The roles of inflammasomes in cancer , 2023, Frontiers in immunology.

[10]  G. Mudó,et al.  Manipulation of HSP70-SOD1 Expression Modulates SH-SY5Y Differentiation and Susceptibility to Oxidative Stress-Dependent Cell Damage: Involvement in Oxotremorine-M-Mediated Neuroprotective Effects , 2023, Antioxidants.

[11]  Liangren Liu,et al.  A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia , 2023, Journal of clinical medicine.

[12]  M. Serrano,et al.  Hallmarks of aging: An expanding universe , 2022, Cell.

[13]  Qingbo Xu,et al.  CD34+ cell atlas of main organs implicates its impact on fibrosis , 2022, Cellular and Molecular Life Sciences.

[14]  Wenhua Zhu,et al.  An update on Ym1 and its immunoregulatory role in diseases , 2022, Frontiers in Immunology.

[15]  Shijun Zhang,et al.  The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases , 2022, Frontiers in Aging Neuroscience.

[16]  R. Nishimura,et al.  Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases , 2022, International journal of molecular sciences.

[17]  M. Tsai,et al.  KIT as a master regulator of the mast cell lineage. , 2022, The Journal of allergy and clinical immunology.

[18]  Ruonan Sun,et al.  Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging , 2022, Frontiers in Immunology.

[19]  S. Perrett,et al.  Hsp70 in Redox Homeostasis , 2022, Cells.

[20]  Z. Qin,et al.  NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1 , 2021, Cell death discovery.

[21]  M. Caffarel,et al.  The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression , 2021, International journal of molecular sciences.

[22]  K. To,et al.  TGF-β Signaling: From Tissue Fibrosis to Tumor Microenvironment , 2021, International journal of molecular sciences.

[23]  L. Toniolo,et al.  The Potential of Calorie Restriction and Calorie Restriction Mimetics in Delaying Aging: Focus on Experimental Models , 2021, Nutrients.

[24]  A. Brunetti,et al.  Overexpression of p75NTR in Human Seminoma: A New Biomarker? , 2021, Life.

[25]  K. Ranganathan,et al.  Immunohistochemical Biomarkers in Oral Submucous Fibrosis - A Scoping Review. , 2021, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[26]  X. Ruan,et al.  Sterol-resistant SCAP Overexpression in Vascular Smooth Muscle Cells Accelerates Atherosclerosis by Increasing Local Vascular Inflammation through Activation of the NLRP3 Inflammasome in Mice , 2021, Aging and disease.

[27]  Xinghuan Wang,et al.  M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin‐like growth factor 1 knockdown , 2021, The Prostate.

[28]  A. Schaeffer,et al.  Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction , 2021, bioRxiv.

[29]  Antonio J. Pérez-Pulido,et al.  Inhibition of the NLRP3 inflammasome prevents ovarian aging , 2020, Science Advances.

[30]  Liangren Liu,et al.  Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia , 2020, Translational andrology and urology.

[31]  Xinghuan Wang,et al.  Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia , 2019, Front. Endocrinol..

[32]  M. Demaria,et al.  Hallmarks of Cellular Senescence. , 2018, Trends in cell biology.

[33]  M. Tsai,et al.  Mast cells as sources of cytokines, chemokines, and growth factors , 2018, Immunological reviews.

[34]  S. Nourshargh,et al.  Human CD8+ EMRA T cells display a senescence‐associated secretory phenotype regulated by p38 MAPK , 2017, Aging cell.

[35]  X. Zu,et al.  Infiltrating mast cells enhance benign prostatic hyperplasia through IL-6/STAT3/Cyclin D1 signals , 2017, Oncotarget.

[36]  Chenyi Jiang,et al.  The androgen receptor plays different roles in macrophage-induced proliferation in prostate stromal cells between transitional and peripheral zones of benign prostatic hypertrophy , 2017, EXCLI journal.

[37]  P. Balasubramanian,et al.  Aging and Caloric Restriction Research: A Biological Perspective With Translational Potential , 2017, EBioMedicine.

[38]  B. Krušlin,et al.  Inflammation in Prostatic Hyperplasia and Carcinoma—Basic Scientific Approach , 2017, Front. Oncol..

[39]  Goto Gangkak,et al.  Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia , 2017, Investigative and clinical urology.

[40]  S. Freedland,et al.  Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention. , 2016, The Journal of urology.

[41]  Judith Jones,et al.  The aging population: demographics and the biology of aging. , 2016, Periodontology 2000.

[42]  A. Tubaro,et al.  Inflammatory mediators in the development and progression of benign prostatic hyperplasia , 2016, Nature Reviews Urology.

[43]  P. Tchounwou,et al.  Oxidative stress in prostate hyperplasia and carcinogenesis , 2016, Journal of Experimental & Clinical Cancer Research.

[44]  Nina M. Muñoz,et al.  A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer12 , 2016, Neoplasia.

[45]  K. Al-Regaiey.  The effects of calorie restriction on aging: a brief review. , 2016, European review for medical and pharmacological sciences.

[46]  X. Zu,et al.  LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia , 2016, Scientific Reports.

[47]  G. López-Lluch,et al.  Calorie restriction as an intervention in ageing , 2016, The Journal of physiology.

[48]  M. Lucia,et al.  Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study. , 2015, The Journal of urology.

[49]  Zhou Wang,et al.  Inflammasomes are important mediators of prostatic inflammation associated with BPH , 2015, Journal of Inflammation.

[50]  S. Gangemi,et al.  Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review , 2014, Urologia Internationalis.

[51]  K. Eliceiri,et al.  Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules , 2014, PloS one.

[52]  T. Miyakawa,et al.  SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system , 2014, Molecular Brain.

[53]  Y. Kojima,et al.  Interleukin‐18 may lead to benign prostatic hyperplasia via thrombospondin‐1 production in prostatic smooth muscle cells , 2014, The Prostate.

[54]  D. DeFranco,et al.  Upregulation of androgen‐responsive genes and transforming growth factor‐β1 cascade genes in a rat model of non‐bacterial prostatic inflammation , 2014, The Prostate.

[55]  Chawnshang Chang,et al.  Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells , 2014, Molecular membrane biology.

[56]  J. Venturini,et al.  Proinflammatory profile of in vitro monocytes in the ageing is affected by lymphocytes presence , 2013, Immunity & Ageing.

[57]  Zhe Wu,et al.  Essential role of stem cell factor–c‐Kit signalling pathway in bleomycin‐induced pulmonary fibrosis , 2013, The Journal of pathology.

[58]  B. Djavan,et al.  Correlation between benign prostatic hyperplasia and inflammation , 2013, Current opinion in urology.

[59]  Chawnshang Chang,et al.  Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. , 2012, Molecular endocrinology.

[60]  Xiaohai Wang,et al.  Increased Infiltrated Macrophages in Benign Prostatic Hyperplasia (BPH) , 2012, The Journal of Biological Chemistry.

[61]  Yahui Kong,et al.  Oxidative Stress, Mitochondrial Dysfunction, and Aging , 2011, Journal of signal transduction.

[62]  A. Kozubík,et al.  TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug , 2011, The Prostate.

[63]  M. Benhamou,et al.  Mast Cells as Cellular Sensors in Inflammation and Immunity , 2011, Front. Immun..

[64]  Hong-Chiang Chang,et al.  Altered prostate epithelial development and IGF‐1 signal in mice lacking the androgen receptor in stromal smooth muscle cells , 2011, The Prostate.

[65]  A. Dillin,et al.  The Cell-Non-Autonomous Nature of Electron Transport Chain-Mediated Longevity , 2011, Cell.

[66]  Peter S. Nelson,et al.  The Effects of Aging on the Molecular and Cellular Composition of the Prostate Microenvironment , 2010, PloS one.

[67]  S. Terry,et al.  Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis , 2009, The Prostate.

[68]  A. Lenzi,et al.  Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism , 2009, Journal of endocrinological investigation.

[69]  Hyunwon Yang,et al.  Inhibition of Thymic Adipogenesis by Caloric Restriction Is Coupled with Reduction in Age-Related Thymic Involution1 , 2009, The Journal of Immunology.

[70]  J. Gustafsson,et al.  A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia , 2009, Proceedings of the National Academy of Sciences.

[71]  H. Motiwala,et al.  Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? , 2007, BJU international.

[72]  G. Kramer,et al.  Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? , 2007, European urology.

[73]  P. Nelson,et al.  The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. , 2006, Cancer research.

[74]  G. Kramer,et al.  Could inflammation be a key component in the progression of benign prostatic hyperplasia? , 2006, Current opinion in urology.

[75]  R. Shah,et al.  CXCL12 overexpression and secretion by aging fibroblasts enhance human prostate epithelial proliferation in vitro , 2005, Aging cell.

[76]  S. Madersbacher,et al.  Benign prostatic hyperplasia: age-related tissue-remodeling , 2005, Experimental Gerontology.

[77]  Günter Lepperdinger,et al.  Profiling molecular targets of TGF-β1 in prostate fibroblast-to-myofibroblast transdifferentiation , 2005, Mechanisms of Ageing and Development.

[78]  P. Boyle,et al.  Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. , 2002, Urology.

[79]  C. Roehrborn,et al.  The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia , 1998 .

[80]  R. Villalobos-Molina,et al.  Effects of calorie restriction and aging on the expression of antioxidant enzymes and ubiquitin in the liver of Emory mice , 1996, Mechanisms of Ageing and Development.

[81]  M. Dizdaroglu,et al.  DNA base modifications and antioxidant enzyme activities in human benign prostatic hyperplasia. , 1995, Free radical biology & medicine.

[82]  I. Sasagawa,et al.  Volume change of the prostate and seminal vesicles in male hypogonadism after androgen replacement therapy , 2006, International Urology and Nephrology.

[83]  J. Trent,et al.  Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. , 2002, Cancer research.

[84]  D. Kirk,et al.  Enhanced expression of the mesenchymal marker, vimentin, in hyperplastic versus normal human prostatic epithelium. , 1998, The Journal of urology.